Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 4/20 | 0.78 |
| ▸ | USP2 | O75604 | 2/20 | 0.78 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6834960 | 1.00 | INMT (0.78) | INMTUSP2BCHEACHEMEN1 | |
| SCHEMBL2927 | 0.97 | — | — | |
| SCHEMBL17417845 | 0.97 | — | — | |
| Water SCHEMBL6561823 | 0.95 | INMT (0.78) | INMTUSP2BCHEACHEMEN1 | |
| SCHEMBL29707902 | 0.95 | INMT (0.78) | INMTUSP2BCHEACHEMEN1 | |
| Hydrochloric Acid SCHEMBL10432356 | 0.95 | INMT (0.78) | INMTUSP2BCHEACHEMEN1 | |
| SCHEMBL1812588 | 0.91 | INMT (0.72) | INMTUSP2BCHEACHEMEN1 | |
| SCHEMBL6211137 | 0.91 | INMT (0.95) | INMTUSP2ACHEALDH1A1SIGMAR1 | |
| Ammonia Solution, Strong SCHEMBL6834929 | 0.91 | INMT (0.95) | INMTUSP2ACHEALDH1A1LMNA | |
| SCHEMBL11028060 | 0.90 | INMT (0.78) | INMTUSP2BCHEACHEMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3877374-B1 | METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS | NECTAR HEALTH SCIENCES INC (CA) | 2024-03-20 | — | — | EP | disclosed |
| US-11208393-B2 | Methods for extraction, processing, and purification of a selected family of target compounds from cannabis | NECTAR HEALTH SCIENCES INC. (CA) | 2021-12-28 | — | — | US | disclosed |
| US-20210309629-A1 | METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS | NECTAR HEALTH SCIENCES INC. (CA) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11208393-B2 | Methods for extraction, processing, and purification of a selected family of target compounds from cannabis | CNR2, CNR1, NOTUM | INMT 134/4885USP2 2334/4885BCHE 217/4885 |
| US-20210309629-A1 | METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS | CNR2, CNR1, NOTUM | INMT 134/4885USP2 2334/4885BCHE 217/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.